Maryland House Bill 736 (Prior Session Legislation)

---

Sponsorship: Partisan Bill (Republican 1)
Status: Introduced on February 6 2013 - 25% progression, died in chamber
Action: 2013-04-08 - Referred to interim study by Health and Government Operations
Text: Latest bill text (Introduced) [PDF]

Requiring the State Board of Pharmacy, in consultation with the University of Maryland School of Pharmacy, to specify the prescription drugs that may be considered specialty drugs by a pharmacy benefits manager; requiring the Board to publish in the Maryland Register a list of the prescription drugs that may be considered specialty drugs; requiring a pharmacy benefits manager to designate on a formulary only prescription drugs that are on the list of specialty drugs published by the Board; etc.

Health Insurance - Pharmacy Benefits Managers - Specialty Drugs

Del. Nicholaus Kipke [R]

Date	Chamber	Action
2013-04-08	House	Referred to interim study by Health and Government Operations
2013-02-21	House	Hearing 2/21 at 1:00 p.m.
2013-02-06	House	First Reading Health and Government Operations

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0736?ys=2013rs
Text	https://mgaleg.maryland.gov/2013RS/bills/hb/hb0736f.pdf
Supplement	https://mgaleg.maryland.gov/2013RS/fnotes/bil_0006/hb0736.pdf
Supplement	https://mgaleg.maryland.gov/2013RS/votes_comm/hb0736_hgo.pdf